Background: Understanding the clinical course and short-term outcomes of suspected
myocarditis after the coronavirus disease 2019 (COVID-19) vaccination has important public�…

Clinical course and outcomes of myocarditis after COVID-19 vaccination remain variable.
We retrospectively collected data on patients> 12 years old from 01/01/2021 to 12/30/2021�…

Background Reports have suggested an association between the development of
myocarditis and the receipt of messenger RNA (mRNA) vaccines against coronavirus�…

Background The coronavirus disease of 2019 (COVID‐19) is a global pandemic with over
266 million cases and 5 million deaths worldwide. Anti‐COVID‐19 vaccinations have had�…

Please see the Editorial Comment by Gloria Caredda discussing this article.
BACKGROUND. A possible association has been reported between COVID-19 messenger�…

Presently, the whole globe is struggling the tough challenge of the COVID-19 pandemic.
Vaccination remains the most effective and safe COVID-19 weapon for adults and in the�…

This is a cross-sectional study of 29 published cases of acute myopericarditis following
COVID-19 mRNA vaccination. The most common presentation was chest pain within 1–5�…

Objectives A clear temporal relationship between myocarditis and pericarditis after COVID-
19 vaccination has led to the belief that the vaccine may act as a trigger for these cardiologic�…

Aims To describe the cardiac magnetic resonance (CMR) imaging findings of patients who
developed myocarditis following messenger RNA (mRNA) coronavirus disease 2019�…

Background There are limited data on the pattern and severity of myocardial injury in
patients with COVID-19 vaccination–associated myocarditis. Purpose To describe�…